AAAAAA

   
Results: 1-8 |
Results: 8
INTERVENTION WITH THE HYPOXIC TUMOR-CELL SENSITIZER ETANIDAZOLE IN THE COMBINED-MODALITY TREATMENT OF LIMITED STAGE SMALL-CELL LUNG-CANCER - A ONE-INSTITUTION STUDY
Authors: URTASUN RC PALMER M KINNEY B BELCH A HEWITT J HANSON J
Citation: Rc. Urtasun et al., INTERVENTION WITH THE HYPOXIC TUMOR-CELL SENSITIZER ETANIDAZOLE IN THE COMBINED-MODALITY TREATMENT OF LIMITED STAGE SMALL-CELL LUNG-CANCER - A ONE-INSTITUTION STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 337-342
GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN
Authors: SHUSTIK C JOHNSTON D JAMES K ZEE B MYER R BELCH A KLASA R MEHARCHAND J PATER J
Citation: C. Shustik et al., GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN, Blood, 90(10), 1997, pp. 1596-1596
RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/
Authors: VANDERJAGT R ROBINSON S GLUCK S BELCH A SHERIDAN D MATTHEWS J LARRATT L MARKMAN S DIPIETRO N PHAM B SHUSTIK C STEWART K
Citation: R. Vanderjagt et al., RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/, Blood, 90(10), 1997, pp. 2264-2264
A MULTICENTER STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH CONSOLIDATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML)
Authors: KEATING A GANDHI MK CRUMP M SMITH A BELCH A BAKER MA
Citation: A. Keating et al., A MULTICENTER STUDY OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH CONSOLIDATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 832-832
TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS IN 99 UNSELECTED ADULTS WITH HIGH-DOSE ARA-C (HIDAC) AND MITOXANTRONE - LONG-TERM FOLLOW-UP
Authors: KEATING A GANDHI MK CRUMP M SMITH A BELCH A BAKER MA
Citation: A. Keating et al., TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS IN 99 UNSELECTED ADULTS WITH HIGH-DOSE ARA-C (HIDAC) AND MITOXANTRONE - LONG-TERM FOLLOW-UP, Blood, 88(10), 1996, pp. 833-833
RANDOMIZED TRIAL OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP
Authors: BROWMAN GP BERGSAGEL D SICHERI D OREILLY S WILSON KS RUBIN S BELCH A SHUSTIK C BARR R WALKER I JAMES K ZEE B JOHNSTON D
Citation: Gp. Browman et al., RANDOMIZED TRIAL OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP, Journal of clinical oncology, 13(9), 1995, pp. 2354-2360
RESPONSE-ADAPTED TREATMENT OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML) - A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMES IDARUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/
Authors: VANDERJAGT R ROBINSON S GLUCK S BELCH A SHERIDAN D MATTHEWS J LARRATT L MARKMAN S DIPIETRO N PHAM B SHUSTIK C STEWART K
Citation: R. Vanderjagt et al., RESPONSE-ADAPTED TREATMENT OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML) - A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMES IDARUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/, Blood, 86(10), 1995, pp. 2051-2051
A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML
Authors: VANDERJAGT R ROBINSON S GLUCK S SHERIDAN D MATHEWS J BELCH A LARRATT L MARKMAN S SHUSTIK C HO AD
Citation: R. Vanderjagt et al., A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML, Blood, 84(10), 1994, pp. 10000304-10000304
Risultati: 1-8 |